In India, a disease is considered rare if it affects fewer than 1 in 2,500 individuals. The lack of a comprehensive registry ...

Find effective medications for 'Gaucher’s Disease treatment right here!' This page is a trusted source for both professionals and patients, detailing brand-name and generic options designed to ...

England’s NHS will routinely fund Sanofi/Genzyme’s Cerdelga (eliglustat) for the rare condition Gaucher disease after a recommendation from NICE. The cost effectiveness body published final ...

Later, in 1951, while working with Dr. Sidney Farber, professor of Pathology at Harvard, Dr. Uzman isolated and described the lipoprotein in Gaucher's disease, an anemia of the spleen that runs in ...

It acquired rights to taligurase alfa, a form of the enzyme glucocerebrosidase in development for the treatment of Gaucher's disease, from Protalix Biotherapeutics in Carmiel, Israel. Protalix has ...

Accumulation of fat molecules is detrimental to the cell. Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have made a breakthrough in ...

AceLink Therapeutics, Inc., a clinical-stage biotech company developing next-generation oral substrate reduction therapies (SRTs), presented interim d ...

Genzyme anticipates supply constraints of Cerezyme (imiglucerase), a treatment for Gaucher disease, and Fabrazyme (agalsidase beta), used to treat Fabry disease, while the facility shuts down for ...